Vitamin E protects against the mitochondrial. damage caused by cyclosporin A in LLC-PK1 cells

被引:25
作者
de Arriba, G. [1 ,2 ,3 ]
Perez de Hornedo, J. [1 ]
Ramirez Rubio, S. [1 ]
Calvino Fernandez, M. [1 ]
Benito Martinez, S. [1 ]
Maiques Camarero, M. [1 ]
Parra Cid, T. [1 ]
机构
[1] Hosp Univ Guadalajara, Unidad Invest, Guadalajara 19002, Spain
[2] Hosp Univ Guadalajara, Secc Nefrol, Guadalajara 19002, Spain
[3] Univ Alcala de Henares, Dept Med, Alcala De Henares 99775, Spain
关键词
Cardiolipin; Cyclosporin A; Mitochondria; Reactive oxygen species; Vitamin E; PERMEABILITY TRANSITION PORE; CYTOCHROME-C; OXIDATIVE STRESS; AUTOIMMUNE-DISEASE; INDUCED APOPTOSIS; CYTOTOXIC AGENTS; ROS RELEASE; CARDIOLIPIN; NECROSIS; DEATH;
D O I
10.1016/j.taap.2009.05.028
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cyclosporin A (CsA) has nephrotoxic effects known to involve reactive oxygen species (ROS), since antioxidants prevent the kidney damage induced by this drug. Given that mitochondria are among the main sources of intracellular ROS, the aims of our study were to examine the mitochondrial effects of CsA in the porcine renal endothelial cell line LLC-PK1 and the influence of the antioxidant Vitamin E (Vit E). Following the treatment of LLC-PK1 cells with CsA, we assessed the mitochondrial synthesis of superoxide anion, permeability transition pore opening, mitochondrial membrane potential, cardiolipin peroxidation, cytochrome c release and cellular apoptosis, using flow cytometry and confocal microscopy procedures. Similar experiments were done after Vit E preincubation of cells. CsA treatment increased superoxide anion in a dose-dependent way. CsA opened the permeability transition pores, caused Bax migration to mitochondria, and decreased mitochondrial membrane potential and cardiolipin content. Also CsA released cytochrome c into cytosol and provoked cellular apoptosis. Vit E pretreatment inhibited the effects that CsA induced on mitochondrial structure and function in LLC-PK1 cells and avoided apoptosis. CsA modifies mitochondrial LLC-PK1 cell physiology with loss of negative electrochemical gradient across the inner mitochondrial membrane and increased lipid peroxidation. These features are related to apoptosis and can explain the cellular damage that CsA induces. As Vit E inhibited these effects, our results suggest that they were mediated by an increase in ROS production by mitochondria. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:241 / 250
页数:10
相关论文
共 69 条
[1]  
[Anonymous], 2003, TOXICOLOGY
[2]   How do Bax and Bak lead to permeabilization of the outer mitochondrial membrane? [J].
Antignani, Antonella ;
Youle, Richard J. .
CURRENT OPINION IN CELL BIOLOGY, 2006, 18 (06) :685-689
[3]   A mechanistic view of mitochondrial death decision pores [J].
Belizario, J. E. ;
Alves, J. ;
Occhiucci, J. M. ;
Garay-Malpartida, M. ;
Sesso, A. .
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2007, 40 (08) :1011-1024
[4]   The mitochondrial permeability transition from in vitro artifact to disease target [J].
Bernardi, P ;
Krauskopf, A ;
Basso, E ;
Petronilli, V ;
Blalchy-Dyson, E ;
Di Lisa, F ;
Forte, MA .
FEBS JOURNAL, 2006, 273 (10) :2077-2099
[5]   A wave of reactive oxygen species (ROS)-induced ROS release in a sea of excitable mitochondria [J].
Brady, Nathan R. ;
Hamacher-Brady, Anne ;
Westerhoff, Hans V. ;
Gottlieb, Roberta A. .
ANTIOXIDANTS & REDOX SIGNALING, 2006, 8 (9-10) :1651-1665
[6]  
CALNE RY, 1978, LANCET, V2, P1323
[7]   Cyclosporine A regulate oxidative stress-induced apoptosis in cardiomyocytes:: mechanisms via ROS generation, iNOS and Hsp70 [J].
Chen, HW ;
Chien, CT ;
Yu, SL ;
Lee, YT ;
Chen, WJ .
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 137 (06) :771-781
[8]   EVIDENCE THAT RENAL PROSTAGLANDIN AND THROMBOXANE PRODUCTION IS STIMULATED IN CHRONIC CYCLOSPORINE NEPHROTOXICITY [J].
COFFMAN, TM ;
CARR, DR ;
YARGER, WE ;
KLOTMAN, PE .
TRANSPLANTATION, 1987, 43 (02) :282-285
[9]   The mitochondrial permeability transition pore and its role in cell death [J].
Crompton, M .
BIOCHEMICAL JOURNAL, 1999, 341 :233-249
[10]   Nephrotoxicity of immunosuppressive drugs: Long-term consequences and challenges for the future [J].
de Mattos, AM ;
Olyaei, AJ ;
Bennett, WM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (02) :333-346